SCHEMBL2494971

SCHEMBL2494971

COc1ccc(-c2cccc(N(C)CCO)c2-c2ccc(OC)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
HDAC4 P56524 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
ABL1 P00519 1/20 0.41
ABCB1 P08183 1/20 0.41
BCR P11274 1/20 0.41
CRHR1 P34998 1/20 0.40
USP2 O75604 1/20 0.40
PTGS2 P35354 1/20 0.38
ENPP1 P22413 1/20 0.38
BACE1 P56817 1/20 0.37
DRD2 P14416 1/20 0.37
ALDH1A1 P00352 1/20 0.36
GRM1 Q13255 1/20 0.36
QPCT Q16769 1/20 0.36
QPCTL Q9NXS2 1/20 0.36
RPS6KA2 Q15349 1/20 0.36
PABPC1 P11940 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2489493 0.75 HDAC4 (0.50) MEN1KMT2AHDAC4HDAC2HDAC8
SCHEMBL16097044 0.72 KMT2A (0.42) MEN1KMT2ACRHR1ALDH1A1
SCHEMBL15859646 0.72 MEN1 (0.64) MEN1KMT2AUSP2ALDH1A1PABPC1
SCHEMBL2495694 0.71 HDAC4 (0.43) MEN1KMT2AHDAC4HDAC2HDAC8
SCHEMBL2490777 0.71 PDE4B (0.42) MEN1KMT2AUSP2ALDH1A1
SCHEMBL15466179 0.71 RPS6KA2 (0.45) MEN1KMT2ARPS6KA2
SCHEMBL11096265 0.71 ABL1 (0.58) HDAC4HDAC2HDAC8ABL1ABCB1
SCHEMBL9959026 0.71 ABL1 (0.46) HDAC4HDAC2HDAC8ABL1ABCB1
SCHEMBL430965 0.71 ABL1 (0.46) HDAC4HDAC2HDAC8ABL1ABCB1
SCHEMBL7024625 0.71 ABL1 (0.46) HDAC4HDAC2HDAC8ABL1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH MEN1 1585/4885KMT2A 2108/4885HDAC4 2018/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 MEN1 1346/4885KMT2A 2219/4885HDAC4 2257/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R MEN1 1200/4885KMT2A 2287/4885HDAC4 2106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.